ArticleCureus2025
Takotsubo Syndrome and Arrhythmias: The Chicken and Egg Dilemma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Takotsubo syndrome (TTS), also known as broken heart syndrome, is a transient and reversible cardiomyopathy characterized by left ventricular dysfunction in the absence of obstructive coronary artery disease. Although often considered benign, TTS can lead to serious arrhythmic complications such as atrioventricular block (AVB) and life-threatening ventricular arrhythmias. We present the case of a 74-year-old woman with cardiovascular risk factors who developed complete AVB and torsades de pointes during the course of a TTS episode. The diagnosis was based on clinical presentation and imaging findings, including recovery of left ventricular ejection fraction. Cardiac magnetic resonance imaging was limited by technical constraints but supported the diagnosis. This case highlights the complex arrhythmic manifestations that may accompany TTS and underscores the importance of careful rhythm monitoring and device selection. Implantable cardioverter-defibrillator therapy was ultimately chosen due to the occurrence of sustained ventricular arrhythmias. Clinicians should be aware that TTS, though reversible, may present with conduction disturbances and ventricular arrhythmias requiring aggressive management and appropriate device implantation strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.